| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.32 | 6e-20 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-17 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-14 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |